Key Takeaways
- Revenue hit by a double shock: International services degrew 6.6% QoQ as the largest TMT client cut deeper than expected and Quant’s seasonal trough landed together, while domestic fell 9.1% on its own seasonality.
- Margins improved despite the top-line miss: EBITDA margin recovered to 16.5% from 14.6% QoQ, helped by the removal of a one-time Q3 discount and operational correction of costs tied to the large-client ramp-down.
- A landmark deal signals demand is not broken: Sonata won its second-largest TCV deal ever, a $73 mn modernization program with a US TMT firm, proving the pipeline can still convert even as retail and manufacturing stay frozen.
- The largest-client reset is not over: Management expects a turn to marginal growth from Q1, but the ramp-down was concentrated in a high-onsite Mexico geography and the client’s fiscal reset only begins July 1, so recovery is gradual and unproven.
- What to watch next quarter: Whether the large TMT deal begins contributing revenue, whether the largest client actually returns to growth, and whether the domestic OEM strategic risk crystallizes into a material number.
The Quarter’s Revenue Shock
- Largest client cut deeper: The TMT client’s budget cuts, flagged in Q3, accelerated in Q4 with an impact significantly larger than management had estimated. The ramp-down was concentrated in a specific program in a newer geography (Mexico), which hurt the top line disproportionately because the lost revenue was mostly onsite.
- Quant seasonality compounded the pain: Quant’s Q4 is always a seasonally declined quarter, and that pattern held. Together, the large client and Quant accounted for the majority of the international services degrowth.
- Domestic business softened on cue: Domestic revenue degrew 9.1% QoQ after a strong Q3, a seasonal move management characterized as anticipated.
- Full-year growth stayed positive: Despite the H2 shock, FY25 international services revenue grew 3.7% YoY, absorbing headwinds in retail, manufacturing, and the largest client.
- No other shoes dropping yet: Management stated that as of today, no major degrowth is expected in other customers, but added the caveat that the situation is uncertain and anything can develop in coming months.
Jagannathan CN: "As of today, whatever information we have as of today we do not expect any major regrowth in other customers. But situation is uncertain. Anything can develop in the coming months."
The Landmark Deal and Pipeline
- Second-largest TCV win in company history: A $73 mn, five-year deal with a leading American TMT company to serve as strategic technology partner for a comprehensive modernization program spanning platforms, data services, Workday, Salesforce, and cybersecurity.
- Deal structure and ramp: The engagement involves re-platforming a B2B technology platform, holding the old system while building the new, sunsetting legacy features, and continuously modernizing other application stacks. It is under transition now, will ramp in waves, and is expected to be fully backed up by end of Q2 or early Q3, with only marginal revenue in Q1.
- Margin impact is manageable: Management called the contract accretive over its five-year term; year one may see a marginal impact, particularly in Q2 and partly Q1, due to transition costs, but nothing significant.
- Pipeline has heft: Several large deals above a certain TCV threshold are in the pipeline, with large deals comprising about 35% of the total pipeline. A couple of pursuits are of comparable scale to the $73 mn win.
- Vertical wins continued: Sonata added a new healthcare logo (one of the Blues) for a multi-year modernization program and a new BFSI logo (a global investment banking firm) to build an AI and automation center of excellence.
Samir Dhir: "This marks the second-largest TCP win in Sonata's 40-year history. Let me repeat, this marks the second-largest TCP win in Sonata's 40-year history, a proud milestone for all of us Sonatians."
Margin Recovery: Mechanics and Outlook
- Q4 margin walk-up: The 190 bps QoQ improvement in international services EBITDA margin had two main drivers. Roughly 40–50% came from the removal of a one-time discount given in Q3. The rest came from operational correction: when the large-client ramp-down hit in Q3, Sonata was left with cost but no revenue; in Q4, it adjusted and that cost went away, plus small operational-efficiency items.
- 20%+ target delayed: Management indicated a possible one-quarter delay in returning to 20%+ EBITDA margins, tying the pace of recovery directly to the turnaround in large customers.
- Depreciation reset: The sizable sequential decline in depreciation and amortization was due to a fair-valuation exercise on a liability done at year-end. Going forward, D&A can increase from here but will not return to the old, higher number.
- Domestic margin is a mix story: Management cautioned against measuring the domestic business on margin percentage alone, arguing it should be judged on gross contribution in absolute terms because product mix, customer requirements, and OEM product changes can shift the percentage.
Jagannathan CN: "We have at present we will year outlook for reaching back to the earlier growth. We may think there can be a one quarter of delay to that, but we are in the track of reaching there."
Vertical and Client Dynamics
| Vertical / Segment | Trend | Commentary |
|---|---|---|
| Healthcare & Life Sciences | ▲ Scaling | New Blues logo onboarded; HFS recognized Sonata as an enterprise innovator for payer transformation; expected to be a significant part of FY26 growth. |
| BFSI | ▲ Scaling, slower | New investment-banking logo added; recovery expected from Q4 to Q1 but full recovery only from Q2; peak numbers expected in Q2–Q3. |
| TMT (largest client) | ▼ Bottoming | Ramp-down in Mexico geography drove the Q4 miss; client consolidated vendors and Sonata gained preferred status in several LOBs; wallet share expected to increase gradually from the client's July 1 fiscal reset. |
| Retail & Manufacturing | ▼ Weak, uncertain | Project closures have nearly offset new wins in recent quarters; management is factoring in degrowth in retail for at least Q1 and Q2; the pattern of measured decision-making is ongoing given US tariffs. |
| Tech Sector | ▲ Positive | Expected to do well in FY26, supported by the large TMT deal and the largest client bottoming out in Q4. |
| Domestic | ▼ Risk flagged | A large OEM client has taken a strategic position that could impact Sonata; management has taken risk-mitigation measures but actual execution by the OEM will determine the impact; clarity may take a couple of quarters. |
- Industry-wide pattern: Retail and manufacturing customers are much more measured in taking decisions, while tech, banking, and healthcare customers are slightly more aggressive, a pattern management sees continuing given US tariff uncertainty.
- Healthcare and BFSI scaling ambition: These two verticals now contribute 35% of international business revenue, up from 13% twelve quarters ago. The long-term aspiration is for the two combined to reach roughly $250 mn, or about a quarter of a $1 bn business, in three to five years.
Samir Dhir: "Retail is the uncertainty right now that we don't know really about. We're factoring in our estimates that retail will degrow in the first half and as market and situation evolves, we'll be sharing with people."
Strategic Bets: AI, Partnerships, and Talent
- AI revenue ambition: AI-enabled services are expected to contribute 20% of revenue over the next three years.
- Partnership ecosystem deepening: Sonata achieved AWS Generative AI Competency, became a member of the Microsoft Partner AI Council, and was recognized as an official Microsoft Fabric feature partner.
- AI wins in the quarter: A new logo in the healthcare insurance space for a GenAI consumer-experience solution; an existing travel client chose Sonata for IT support improvement; a technology company client is using AI for contract loading, audit rules, and operational analytics.
- Workforce AI-ready: 97% of the workforce is trained in Gen AI. Active headcount grew to over 6,800 from 6,619 at the start of FY25, with LTM attrition at 14% and gender diversity at 31%.
- Near-shore expansion: Sonata scaled its near-shore presence in Mexico and Malaysia, with both centers together now exceeding 100 professionals.
- SOC business ambition: The newly established SOC business within SITL is projected to contribute 20% of SITL’s growth within the next three to five years.
- Technology leadership restructured: Hanumanth and Manu Swami now jointly lead global technology practices in a two-in-a-box model, reporting to Raj within the CTO organization.
Guidance & Commitments
| Commitment | Specifics | Timeline |
|---|---|---|
| Largest client recovery | Turn the corner and return to marginal growth from Q1 onwards; wallet share to increase gradually from client's fiscal reset. | Q1 FY26 (marginal growth); July 1 reset |
| Quant recovery | Bounce to growth in Q1 and scale to planned revenue growth by Q2. | Q1 growth; Q2 scale |
| Large TMT deal ramp-up | Marginal revenue in Q1; fully backed up by end of Q2 or early Q3. | End Q2 / early Q3 FY26 |
| EBITDA margin target | Return to 20%+ margins, with a possible one-quarter delay; recovery pace tied to large-customer turnaround. | FY26, possibly delayed by one quarter |
| Retail vertical outlook | Factoring in degrowth in retail for at least the first half of FY26. | Q1 and Q2 FY26 |
| Healthcare and BFSI scale | Combined revenue to reach ~$250 mn. | 3–5 years |
| AI revenue contribution | AI-enabled services to contribute 20% of revenue. | 3 years |
| SOC business contribution | SOC to contribute 20% of SITL growth. | 3–5 years |
| Long-term aspirational goal | Directional goal of $1.5 bn; near-term focus on being in the top 4–5 publicly listed midsize companies (top quartile). | 3–4 years (directional) |
| Domestic OEM risk | Strategic position taken by a large OEM client could impact Sonata; management has taken risk measures but actual impact depends on OEM execution; clarity expected in a couple of quarters. | Clarity in a couple of quarters |
Key Metrics
| Metric | Q4 FY25 |
|---|---|
| Consolidated revenue | ₹2,617.2 cr, degrowth of 7.9% QoQ and growth of 19.4% YoY |
| International services revenue | $81.3 million, degrowth of 6.6% QoQ and 0.5% YoY; constant currency degrowth of 7.2% QoQ and 0.3% YoY |
| International services rupee revenue | ₹702.3 cr, degrowth of 4% QoQ and growth of 3.4% YoY |
| Domestic business revenue | ₹1,918.2 cr, degrowth of 9.1% QoQ and growth of 26.6% YoY |
| International services EBITDA margin | 16.5%, improved from 14.6% in Q3 FY25 |
| International services FY25 EBITDA margin | 17%, compared to 21% in FY24 |
| Consolidated PAT before exceptional item | ₹107.5 cr, growth of 2.4% QoQ and degrowth of 2.6% YoY |
| Consolidated EPS | ₹3.87 per share, increased 2.4% QoQ from ₹3.78 in Q3 FY25 |
| International services order book book-to-bill | 1.25x, over ₹10 cr of booking in the quarter |
| Large deals won in Q4 FY25 | 2 large deals |
| Large deal TCV (second-largest in Sonata history) | $73 million, five-year contract; ramp-up expected largely in Q2 and fully in Q3 FY26 |
| Total headcount | 6,810, down from 7,019 at end of Q3 FY25 |
| LTM attrition rate | 14%, same as Q3 FY25 |
| Utilization | 87%, flat QoQ |
| International services DSO (revised methodology) | 61 days, improved from 64 days in Q3 FY25 |
| Domestic business DSO (revised methodology) | 46 days, improved from 51 days in Q3 FY25 |
| Top 10 clients revenue contribution | 61%, compared to 66% in Q3 FY25 |
| New customers added in Q4 FY25 | 14 |
| Healthcare and BFSI verticals contribution to international revenue | 35%, up from 13% twelve quarters ago |
| AI pipeline | $34 million across 100+ clients |
| Consolidated ROCE | 21.9% |
| Consolidated RONW | 25.2% |
| Domestic business ROCE (SITL) | 43.2% |
| Final dividend recommended | ₹4.4 per share |
| Operating cash flow to EBITDA (FY25) | 93.3% |
| Closing cash balance (FY25) | ₹707 cr |